González-Bonilla EA, Rosas-Nava JE, Sánchez-Núñez JE, Doria-Lozano MI, Corona-Montes VE, Jaspersen-Gastélum J

Language: English
References: 13
Page: 1-6
PDF size: 124.66 Kb.

ABSTRACT

On March 11, 2020, coronavirus disease 2019 (COVID-19) was declared a pandemic and has created an impact like no other on health systems worldwide. A restructuring in the priority of patient care has currently taken place that is based on the patient’s underlying pathology. Urology services are no exception, postponing all the elective surgeries that can be delayed without putting the patient at risk.
A surgical protocol has been adopted during the pandemic that attempts to reduce the amount of time the operating room is in use, as well as the risk for postoperative complications, so that hospital stay can be reduced. In such a setting, minimally invasive surgery, such as laparoscopic and robotic-assisted surgery, can play a beneficial role in treating oncologic pathologies that cannot be deferred.
Based on the best evidence that has currently been published and the guidelines of international associations, this paper summarizes the recommendations regarding urologic laparoscopic and robotic-assisted surgery in times of COVID-19.

REFERENCES

1. Ficarra V, Novara G, Abrate A, Bartoletti R, Crestani A, De Nunzio C, et al. Urology practice during COVID-19 pandemic. Minerva Urologica e Nefrologica= The Italian Journal of Urology and Nephrology. 2020; Available from: https:// doi.org/10.23736/S0393-2249.20.03846-1

2. Naspro R, Da Pozzo LF. Urology in the time of corona. Nat Rev Urol. 2020 May;17(5):251–3. doi: https://doi.org/10.1038/s41585-020- 0312-1

3. American College of Surgeons. COVID-19: recommendations for management of elective surgical procedures. 2020.

4. Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). SAGES and EAES Recommendations Regarding Surgical Response to COVID-19 Crisis. SAGES. 2020. [accessed 13 May 2020] Available from: https:// www.sages.org/recommendations-surgicalresponse- covid-19/

5. Alp E, Bijl D, Bleichrodt RP, Hansson B, Voss A. Surgical smoke and infection control. J Hosp Infect. 2006 Jan;62(1):1–5. doi: https://doi. org/10.1016/j.jhin.2005.01.014

6. Gloster HM, Roenigk RK. Risk of acquiring human papillomavirus from the plume produced by the carbon dioxide laser in the treatment of warts. Journal of the American Academy of Dermatology. 1995 Mar 1;32(3):436–41. doi: https://doi.org/10.1016/0190-9622(95)90065-9

7. Johnson GK, Robinson WS. Human immunodeficiency virus-1 (HIV-1) in the vapors of surgical power instruments. Journal of Medical Virology. 1991;33(1):47–50. doi: https://doi.org/10.1002/jmv.1890330110

8. Zheng MH, Boni L, Fingerhut A. Minimally Invasive Surgery and the Novel Coronavirus Outbreak: Lessons Learned in China and Italy. Annals of Surgery. 2020 Mar;1. doi: https://doi. org/10.1097/sla.0000000000003924

9. Morris SN, Fader AN, Milad MP, Dionisi HJ. Understanding the “Scope” of the Problem: Why Laparoscopy Is Considered Safe during the COVID-19 Pandemic. Journal of Minimally Invasive Gynecology. 2020 May 1;27(4):789–91. doi: https://doi.org/10.1016/j. jmig.2020.04.002

10. Balibrea JMose, Badia JMose, Rubio Pérez I, Martín Antona E, Álvarez Peña E, García Botella S, et al. Manejo quirúrgico de pacientes con infección por COVID-19. Recomendaciones de la Asociación Española de Cirujanos. Cirugía Española. 2020 May;98(5):251–9. doi: https:// doi.org/10.1016/j.ciresp.2020.03.001

11. American Society of Anesthesiologists. Coronavirus Resources – COVID – 19 FAQs. 2020. [accessed 13 May 2020] Available from: https://www.asahq.org/about-asa/governanceand- committees/asa-committees/committee-onoccupational- health/coronavirus/clinical-faqs

12. Mottrie A. ERUS (EAU Robotic Urology Section) guidelines during COVID-19 emergency. 2020;6.

13. University of Nebraska Medical Center. Laparoscopy Adjustments During COVID-19. 2020. [accessed 13 May 2020] Available from: https://www.nebraskamed.com/sites/default/ files/documents/covid-19/laparoscopycovid- 19.pdf